Why Higher THC Exposure Does Not Necessarily Mean Stronger THC Effects
THC blood levels vs effects is one of the most misunderstood concepts in cannabis medicine. A new study found that CBD increased THC exposure in the bloodstream after vaporized cannabis use. However, higher THC blood concentrations do not automatically…
Research on cannabis’s brain effects reveals a complex and uncertain picture.
Emerging research on cannabis brain effects reveals a complex and uncertain picture. Clinicians must understand these effects to counsel patients effectively. The evidence highlights both potential cognitive risks and the need for cautious interpretation.
Endocannabinoid System Research: Cannabis for Anxiety Care
Endocannabinoid system cannabis anxiety care research highlights the clinical importance of cannabinoid composition and product type. Cannabis use for anxiety relief varies significantly between flower and edible products. Understanding these differences…
Unsung Cannabis Crusader: The Untold Story of Medical Marijuana & Cancer
Cannabis pharmacology cancer research reveals how cannabinoids interact with cancer biology and symptom management. Raphael Mechoulam's pioneering studies laid the groundwork for clinical interest in medical marijuana for cancer patients. Understanding…
In the Mix: 9 More Articles — April 09, 2026
The psychedelics therapy pilot program is expanding as Connecticut anticipates FDA approval, signaling important regulatory shifts in 2026. This development highlights evolving drug policies relevant to cannabis and related therapies. Clinicians should…
Why Do Cannabis Users Weigh Less? The Cannabis Weight Loss Paradox Explained
The cannabis weight loss paradox describes the surprising association between cannabis use and lower body weight. This paradox challenges common beliefs about cannabis stimulating appetite. Understanding cannabis metabolic effects is crucial for clinical…
New York Approves Medical Cannabis for Anxiety Despite Limited Evidence
New York's medical cannabis anxiety policy marks a significant regulatory change. Despite approval, clinical evidence supporting cannabis for anxiety disorders remains limited. Patients and clinicians face challenges navigating this evolving landscape.
Cresco Labs Joins Texas Medical Cannabis Program
Cresco Labs has been awarded a license in the Texas medical cannabis program, which restricts products to low THC levels. This expansion may improve patient access to standardized cannabis products. However, the program's narrow qualifying conditions…
Faster Cannabinoid Bioavailability: A 2025 Nanoemulsion Study
This cannabinoid bioavailability review examines a 2025 crossover study testing a nanoemulsified THC/CBD powder against standard oil drops in healthy volunteers. The study found faster absorption and higher cannabinoid exposure with the powder…
Cannabis and Inflammation: Clinical Mechanisms
Cannabis anti-inflammatory mechanisms involve THC and CBD interacting with cannabinoid receptors to reduce inflammatory markers. These mechanisms modulate cytokines such as TNF-alpha, IL-6, and IL-8. Understanding these pathways supports clinical…